Champignon provides an update on its current trading halt and other corporate matters.
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
Champignon provides an update on its current trading halt and other corporate matters.
A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.
MagicMed files with the USPTO with respect to its "broad portfolio of novel psilocybin molecular derivatives, the Psybrary™".
PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.
Atai Life Sciences is bolstering its R&D platform with the acquisition of New York-based Kures.
Oregon could become the first U.S. state to LEGALIZE the (medicinal) use of a psychedelic drug.